Comparative Analysis of Gelatin/Polylactic Acid and Commercial PLA Membranes for Guided Bone Regeneration: A Randomized Clinical Trial.

Med Sci Monit

Department of Oral Implantology, The Affiliated Stomatology Hospital, Jiangxi Medical College, Nanchang University, Jiangxi Province Key Laboratory of Oral Biomedicine, Jiangxi Province Clinical Research Center for Oral Disease, Nanchang, Jiangxi, China.

Published: January 2025

BACKGROUND This study included 32 patients with single missing teeth and alveolar bone defects and aimed to compare outcomes from guided bone regeneration with a gelatin/polylactic acid (GT/PLA) barrier membrane and a Guidor® bioresorbable matrix barrier dental membrane. MATERIAL AND METHODS A total of 32 participants were recruited in the clinical study, with single missing teeth and alveolar bone defects, requiring guided bone regeneration (32 missing teeth in total). They were randomly divided into the GT/PLA membrane group (experimental) and Guidor® membrane group (control) by the envelope method (n=16). Both membranes were used intraoperatively to cover the bone substitute material. Cone beam computed tomography (CBCT) was performed immediately and at 6 months after surgery to assess the amount of bone resorption. In addition, the osteogenic efficacy was calculated. The soft tissue index (STI), wound healing, membrane exposure, and incidence of infection in the operative area were evaluated. RESULTS The implant survival rate was 100% in both groups. The average bone resorption was 148.54±107.42 mm³ in the experimental group and 185.25±85.31 mm³ in the control group (P=0.163); the osteogenic efficacy was 75% in the experimental group and 56% in the control group (P=0.458). Moreover, the parameters of STI, wound healing, membrane exposure, and incidence of infection in the operative area showed no statistically significant difference between the 2 groups (P>0.05). CONCLUSIONS The GT/PLA barrier membrane yielded non-inferior clinical and imaging results to the GUIDOR® membrane, exhibiting good efficacy and biocompatibility in GBR.

Download full-text PDF

Source
http://dx.doi.org/10.12659/MSM.944713DOI Listing

Publication Analysis

Top Keywords

guided bone
12
bone regeneration
12
missing teeth
12
gelatin/polylactic acid
8
bone
8
single missing
8
teeth alveolar
8
alveolar bone
8
bone defects
8
gt/pla barrier
8

Similar Publications

Lung cancer (LC) is a crucial rapidly developing disease. In Egypt, it is one of the five most frequent cancers. Little is known about the impact of deleted mismatch repair genes and its correlation to clinicopathological characteristics.

View Article and Find Full Text PDF

Chitosan-based dental barrier membrane for periodontal guided tissue regeneration and guided bone regeneration: A review.

Int J Biol Macromol

January 2025

School of Materials and Mineral Resources Engineering, Engineering Campus, Universiti Sains Malaysia, 14300 Nibong Tebal, Penang, Malaysia. Electronic address:

Guided tissue regeneration (GTR) and guided bone regeneration (GBR) are two common dental regenerative procedures used to repair periodontal defects caused by periodontitis. In both procedures, a barrier membrane is placed at the interface between the soft tissue and the periodontal defect, serving to impede the infiltration of soft tissue while creating a secluded space for periodontal regeneration. Recently, barrier membranes based on chitosan (CS) have emerged as a promising avenue for these applications.

View Article and Find Full Text PDF

Aetiology, diagnosis and treatment of thalassemia-associated osteoporosis of the adult.

J Endocrinol Invest

January 2025

Section of Endocrinology, Geriatrics and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.

Aim: This review aims to overview factors contributing to TAO development and addresses the targeted diagnostic work-up and treatment management in adult thalassemic patients.

Results: Osteoporosis management in Thalassemia is challenging because several factors contributing to its pathogenesis should be considered and controlled starting from child- hood. A multidisciplinary approach is crucial.

View Article and Find Full Text PDF

This study tested whether combined ceftriaxone and adipose-derived mesenchymal stem cells (ADMSCs) would defend the spinal cord against acute spinal infection (ASI) in rodent. Adult-Male-SD rats were grouped into groups 1 (SC)/2 (ASI)/3 (ASI + ceftriaxone from days 2 to 28 after ASI induction)/4 (ASI + allogenic ADMSCs from day 2 for a total of 3 doses/3 consecutive intervals by intravenous injection)/5 (ASI + combined ceftriaxone and ADMSC) and spinal cord tissues were harvested by day 28. Circulatory levels of TNF-α/IL-6 at days 7 and 28, and these two parameters in spinal fluid at day 28 were lowest in group 1, highest in group 2, significantly lower in group 5 than in groups 3/4, and significantly lower in group 3 than in group 4 (all p < 0.

View Article and Find Full Text PDF

Polysaccharide-based biomaterials for regenerative therapy in intervertebral disc degeneration.

Mater Today Bio

February 2025

Department of Orthopaedic Surgery, The Fourth Affiliated Hospital of Soochow University, Suzhou Medical College, Soochow University, Suzhou, 215000, China.

Intervertebral disc (IVD) degeneration represents a significant cause of chronic back pain and disability, with a substantial impact on the quality of life. Conventional therapeutic modalities frequently address the symptoms rather than the underlying etiology, underscoring the necessity for regenerative therapies that restore disc function. Polysaccharide-based materials, such as hyaluronic acid, alginate, chitosan, and chondroitin sulfate, have emerged as promising candidates for intervertebral disc degeneration (IVDD) therapy due to their biocompatibility, biodegradability, and ability to mimic the native extracellular matrix (ECM) of the nucleus pulposus (NP).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!